查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566928

可吸收纤维蛋白胶贴片市场：按应用、最终用户划分：2024-2033 年全球机会分析与产业预测

Absorbable Fibrin Sealant Patch Market By Application , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 228 Pages | 商品交期: 2-3个工作天内

价格
简介目录

可吸收纤维蛋白胶贴片市场

2023年可吸收纤维蛋白胶贴片市值为3亿美元，预计2024年至2033年复合年增长率为7.8%，到2033年将达7亿美元。

可吸收纤维蛋白胶贴片是外科手术中用于控制出血和促进组织癒合的无菌物品。可吸收纤维蛋白胶贴片是一种生物分解性的贴片，由马胶原蛋白海绵、纤维蛋白原和凝血酶组成。随着时间的推移，贴片配方会被人体吸收，无需将其去除并降低感染疾病风险。密封剂贴片通常用于传统缝合或缝合难以或不足以止血的手术。

由于心血管、整形外科和一般健康併发症的盛行率不断增加，世界各地外科手术的效果不断提高，这是可吸收纤维蛋白胶贴片市场的主要驱动因素。此外，微创手术的普及正在推动密封剂贴片的采用，因为它们可以消除康復后的併发症。作为一种新兴趋势，密封剂贴片在两侧同样活跃和有效，并且越来越受欢迎。据报道，与传统补片相比，新型密封剂补片可在 30 分钟内止血，平均快速六倍。

然而，与传统手术相比，使用密封剂贴片进行的外科手术成本相当高，这就是为什么有些人不喜欢密封剂贴片的原因。这是可吸收纤维蛋白胶贴片市场的主要限制因素。相反，密封剂补片的不断进步预计将为市场扩张提供有利可图的机会。根据英国科学杂誌《自然》发表的研究预测，下一代贴片正在设计中，可提供即时黏附，与快速光投射相容，并具有提供治疗​​的潜力。

板块回顾

可吸收纤维蛋白胶贴片市场按应用、最终用户和地区细分。依应用范围分为一般外科、心血管外科、伤口处理、整形外科、泌尿系统、眼科等。依最终使用者分类，可分为医院和诊所、门诊手术中心等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从应用来看，另一个细分市场主导吸收性纤维蛋白胶贴片市场。

从最终用户来看，医院和诊所占有很高的份额。

按地区划分，预计到 2033 年，北美地区的收益将最高。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章可吸收纤维蛋白胶贴片市场：依应用分类

  • 市场概况
  • 一般外科
  • 心血管外科
  • 伤口处理
  • 整形外科
  • 泌尿系统
  • 眼科手术
  • 其他的

第五章可吸收纤维蛋白胶贴片市场：依最终用户分类

  • 市场概况
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第六章可吸收纤维蛋白胶贴片市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国可吸收纤维蛋白胶贴片市场
    • 加拿大可吸收纤维蛋白胶贴片市场
    • 墨西哥吸收性纤维蛋白胶贴片市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国可吸收纤维蛋白胶贴片市场
    • 法国可吸收纤维蛋白胶贴片市场
    • 英国可吸收纤维蛋白胶贴片市场
    • 义大利可吸收纤维蛋白胶贴片市场
    • 西班牙可吸收纤维蛋白胶贴片市场
    • 其他欧洲国家吸收性纤维蛋白胶贴片市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本可吸收纤维蛋白胶市场
    • 中国吸收性纤维蛋白胶贴片市场
    • 印度可吸收纤维蛋白胶贴片市场
    • 澳洲可吸收纤维蛋白胶贴片市场
    • 韩国吸收性纤维蛋白胶贴片市场
    • 其他亚太地区吸收性纤维蛋白胶贴片市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西可吸收纤维蛋白胶贴片市场
    • 沙乌地阿拉伯可吸收纤维蛋白胶贴片市场
    • 南非可吸收纤维蛋白胶贴片市场
    • 其他拉丁美洲/中东/非洲吸收性纤维蛋白胶贴片市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • Johnson And Johnson
  • Baxter International Inc
  • Takeda Pharmaceutical Company Limited
  • Becton, Dickinson And Company.
  • Corza Medical
  • LifeBond Ltd
  • Surgical Specialties Corporation
  • Biegler GmbH
  • Cohera Medical Inc
  • Integra LifeSciences Corporation
简介目录
Product Code: A323960

Absorbable Fibrin Sealant Patch Market

The absorbable fibrin sealant patch market was valued at $0.3 billion in 2023 and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

An absorbable fibrin sealant patch is a sterile object used in surgical procedures to control bleeding and promote tissue healing. It is a biodegradable patch comprising of equine collagen sponge along with fibrinogen and thrombin, elements which are the key players in the natural blood clotting mechanism of the body. The formulation of the patch involves absorption by the body over time, hence eradicating the need for removal and reducing the risk of infections. The sealant patch is significantly administered during surgeries in which conventional stapling or suturing is difficult or insufficient for hemostasis.

Rise in the conduction of surgical procedures across the globe due to increase in prevalence of cardiovascular, orthopedic, and general health complications is a key driver of the absorbable fibrin sealant patch market. Moreover, surge in the popularity of minimally invasive operations is boosting the adoption of sealant patches as they eliminate the post-recovery intricacies. As an emerging trend, sealant patches that are equally active and effective on both sides are acquiring traction. When compared to the conventional patches, the new sealant patches are reported to be quick by an average of six times, ceasing bleeding in 30 minutes.

However, the cost of surgical procedures involving the use of sealant patches is significantly high as compared to the traditional surgeries, which deters several individuals from preferring them. This acts a major restraint for the absorbable fibrin sealant patch market. On the contrary, constant advancements in sealant patches are expected to present lucrative opportunities for market expansion. According to a study published in Nature, a British scientific journal, next generation of patches are being designed that are projected to provide instant adhesion, possess compatibility with rapid photo-projection, and have the potential to deliver therapeutics.

Segment Review

The absorbable fibrin sealant patch market is segmented into application, end user, and region. On the basis of application, the market is divided into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, and others. As per end user, it is classified into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of application, the others segment dominates the absorbable fibrin sealant patch market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global absorbable fibrin sealant patch market include Johnson & Johnson, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

  • General Surgery
  • Cardiovascular Surgery
  • Wound Management
  • Orthopedic Surgery
  • Urological Surgery
  • Ophthalmic Surgery
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Johnson & Johnson
    • Baxter International Inc
    • Takeda Pharmaceutical Company Limited
    • Becton, Dickinson and Company.
    • Corza Medical
    • LifeBond Ltd
    • Surgical Specialties Corporation
    • Biegler GmbH
    • Cohera Medical Inc
    • Integra LifeSciences Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Application
  • 4.2. General Surgery
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Cardiovascular Surgery
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Wound Management
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Orthopedic Surgery
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Urological Surgery
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country
  • 4.7. Ophthalmic Surgery
    • 4.7.1. Key Market Trends, Growth Factors and Opportunities
    • 4.7.2. Market Size and Forecast, By Region
    • 4.7.3. Market Share Analysis, By Country
  • 4.8. Others
    • 4.8.1. Key Market Trends, Growth Factors and Opportunities
    • 4.8.2. Market Size and Forecast, By Region
    • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Application
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Absorbable Fibrin Sealant Patch Market
      • 6.2.5.1. Market Size and Forecast, By Application
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Absorbable Fibrin Sealant Patch Market
      • 6.2.6.1. Market Size and Forecast, By Application
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Absorbable Fibrin Sealant Patch Market
      • 6.2.7.1. Market Size and Forecast, By Application
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Application
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Absorbable Fibrin Sealant Patch Market
      • 6.3.5.1. Market Size and Forecast, By Application
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Absorbable Fibrin Sealant Patch Market
      • 6.3.6.1. Market Size and Forecast, By Application
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Absorbable Fibrin Sealant Patch Market
      • 6.3.7.1. Market Size and Forecast, By Application
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Absorbable Fibrin Sealant Patch Market
      • 6.3.8.1. Market Size and Forecast, By Application
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Absorbable Fibrin Sealant Patch Market
      • 6.3.9.1. Market Size and Forecast, By Application
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Absorbable Fibrin Sealant Patch Market
      • 6.3.10.1. Market Size and Forecast, By Application
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Application
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Absorbable Fibrin Sealant Patch Market
      • 6.4.5.1. Market Size and Forecast, By Application
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Absorbable Fibrin Sealant Patch Market
      • 6.4.6.1. Market Size and Forecast, By Application
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Absorbable Fibrin Sealant Patch Market
      • 6.4.7.1. Market Size and Forecast, By Application
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Absorbable Fibrin Sealant Patch Market
      • 6.4.8.1. Market Size and Forecast, By Application
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Absorbable Fibrin Sealant Patch Market
      • 6.4.9.1. Market Size and Forecast, By Application
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Absorbable Fibrin Sealant Patch Market
      • 6.4.10.1. Market Size and Forecast, By Application
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Application
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Absorbable Fibrin Sealant Patch Market
      • 6.5.5.1. Market Size and Forecast, By Application
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Absorbable Fibrin Sealant Patch Market
      • 6.5.6.1. Market Size and Forecast, By Application
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Absorbable Fibrin Sealant Patch Market
      • 6.5.7.1. Market Size and Forecast, By Application
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Absorbable Fibrin Sealant Patch Market
      • 6.5.8.1. Market Size and Forecast, By Application
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Johnson And Johnson
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Baxter International Inc
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Takeda Pharmaceutical Company Limited
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Becton, Dickinson And Company.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Corza Medical
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. LifeBond Ltd
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Surgical Specialties Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Biegler GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Cohera Medical Inc
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Integra LifeSciences Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments